Xigduo XR 5 mg / 500 mg

Xigduo XR 5 mg / 500 mg is a medicine authorised by Swissmedic under authorisation number 65377. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 July 2015 and the authorisation is valid without a time limit. ATC code A10BD15 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 65377
  • ATC A10BD15
  • Synthetic medicines
Authorisation data
Authorisation number65377
NameXigduo XR 5 mg / 500 mg
Full nameXigduo XR 5 mg / 500 mg, Filmtabletten
Authorisation holderAstraZeneca AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BD15
First authorisation16 July 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Xigduo XR 5 mg / 500 mg, FilmtablettenB16 July 2015
2Xigduo XR 10 mg / 500 mg, FilmtablettenB16 July 2015
3Xigduo XR 5 mg / 1000 mg, FilmtablettenB16 July 2015
4Xigduo XR 10 mg / 1000 mg, FilmtablettenB16 July 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)A10BD1507.06.2.B
298Tablette(n)A10BD1507.06.2.B
328Tablette(n)A10BD1507.06.2.B
498Tablette(n)A10BD1507.06.2.B
528Tablette(n)A10BD1507.06.2.B
698Tablette(n)A10BD1507.06.2.B
728Tablette(n)A10BD1507.06.2.B
898Tablette(n)A10BD1507.06.2.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Xigduo XR 5 mg / 500 mg authorised in Switzerland?

Yes. Xigduo XR 5 mg / 500 mg is authorised by Swissmedic under authorisation number 65377, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Xigduo XR 5 mg / 500 mg have?

Xigduo XR 5 mg / 500 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Xigduo XR 5 mg / 500 mg?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com